GKA Blog

From the patient’s perspective… Haemophilia

Posted by GKA on 12/02/19 09:52

There are an estimated 400,000 people worldwide living with haemophilia, with approximately 6,000 sufferers in the UK alone. Haemophilia is an inherited disorder that affects the body’s ability to clot. Usually, when someone cuts themselves, clotting factors and platelets combine to make the blood stickier and stop the bleeding. However, in haemophiliacs, the bleeding episodes last longer due to abnormal clotting, and bruising and spontaneous bleeding can also occur too. The main problem for haemophiliacs is internal bleeding into joints, muscles and soft tissues, which can cause pain and stiffness and ultimately lead to joint damage. To better our understanding of the patient's perspective when it comes to market research studies, we spoke to someone who recently took part in haemophilia research with GKA.

Read More

Topics: healthcare market research

Who’s who in Breast Cancer

Posted by GKA on 06/02/19 15:01

The lowdown

Breast cancer is the most common type of cancer in the UK, with one person diagnosed every 10 minutes. Cancer Research UK predicts that one in eight women in the UK will develop breast cancer within their lifetimes, an increase of 50% over the last 25 years - making breast cancer market research a fast-growing fieldwork area. There are around 55,000 new cases of breast cancer reported in women in the UK every year, and although it’s much less common in men, there are still 390 male cases reported each year.

Read More

Topics: Therapy Area Information

Biosimilars: what are they and what do they mean for the NHS?

Posted by GKA on 31/01/19 12:11

 What are biosimilars?

A biological medicine is a type of treatment for long-term medical conditions such as rheumatoid arthritis, Crohn’s disease and psoriasis that’s given via a drip or an injection pen. A biosimilar medicine is simply a newer version of the original biological drug: as the name suggests, it’s highly similar to EMA-approved biological medicines in terms of safety, purity and potency, and it works in much the same way. There are no clinically meaningful differences, just minor differences in clinically inactive components being allowed, and they have to go through the same rigorous scientific assessments before becoming available on the market.

So how are they different to biological drugs? Well, instead of being created using chemical synthesis, biosimilars are synthesised from living organisms or their products, such as hormones, proteins yeast or bacteria. As a result, the molecules within the drug could vary slightly between different batches, which means research and development takes an average of about 10 years. In addition, biosimilars can only become available once a branded drug patent expires - and according to Pfizer, approximately 100 biologic products will lose patent or other protections by 2022, which means newer and cheaper biosimilar products will soon become available.

Read More

Topics: healthcare market research

Five reasons recruitment has been difficult for your fieldwork project

Posted by GKA on 28/01/19 09:45

Are you finding your medical fieldwork recruitment harder than you expected? Or perhaps you are unsure as to why your recruitment agency is taking so long to recruit your sample? Don’t worry - recruitment can be tricky at the best of times, and when it comes to sourcing high-quality respondents for healthcare market research, it can be even more frustrating. From busy HCPs to rare therapy areas, there’s so much to think about that sometimes when it comes to figuring where you might have tripped up, you can’t see for looking. And that’s exactly why we’ve written this blog! Read on and discover the five most common reasons why your medical fieldwork recruitment might be a little bit more difficult than you expected - and what you can do to fix it!

Read More

The history of the NHS

Posted by GKA on 24/01/19 16:13

Technically, the NHS officially began on 5th July 1948. Prior to this, local governments were responsible for running their hospitals, which meant that many hospitals weren’t adequately equipped, struggled to cater for people's needs and were inaccessible for the poor. It also meant the quality of care varied hugely from place to place, with rural areas having very limited access to hospitals and healthcare.

Read More

Topics: medical market research

The arrival of 5G and what it means for healthcare

Posted by GKA on 18/12/18 11:43

Thanks to apps, wearables and other connected devices, patients have never been in more control of their health. All of this new technology in the healthcare industry has huge benefits for stakeholders. So, if the industry wants to keep up with patient demands, it needs to reduce costs and improve efficiency - and next generation networks such as 5G are set to be a pivotal part of this transformation.

Read More

Topics: Healthcare Technology

From the patient's perspective… Narcolepsy

Posted by GKA on 11/12/18 16:32

Narcolepsy is a rare neurological condition that causes a person to suddenly fall asleep at inappropriate times. It means the brain is unable to regulate sleeping and waking patterns normally, resulting in excessive daytime sleepiness, sleep attacks where sufferers fall asleep suddenly and without warning, cataplexy (a temporary loss of muscle control resulting in weakness and possible collapse), sleep paralysis, and excessive dreaming and waking in the night. Although narcolepsy doesn't cause serious or long-term physical health problems, it can have a significant impact on daily life and be difficult to cope with emotionally. In this blog, we interview a patient who took part in a narcolepsy study, in order to humanise our patient journey research.

Read More

Topics: Patient Market Research

Who’s who in Alzheimer's? A medical fieldwork guide

Posted by GKA on 07/12/18 11:45

Alzheimer’s is a physical disease that affects the brain and is the most common type of dementia in the UK. Over time, the disease causes proteins to build up in the brain and form structures called ‘plaques’ and ‘tangles’. These proteins lead to the loss of connections between nerve cells, eventually resulting in the death of the cells and loss of brain tissue. Additionally, Alzheimer's sufferers also have a shortage of vital chemicals which help to transmit signals around the brain, meaning that the signals aren’t transmitted effectively.

Read More

Topics: healthcare market research

Your guide to conducting medical market research in London

Posted by GKA on 14/11/18 13:00

There’s a lot to think about when conducting a medical market research project in a big city such as London. You might think that it is super easy to recruit in such a large city, but once you take into account the ever-increasing amount of qualifying criteria, it can actually become tricky whatever your chosen location. From the type of venue you choose to how many people you recruit, which specialist centres and hospitals you recruit from to any events occurring in the city that could impact your research on the day, there are lots of different things for medical market research companies to consider. Don’t worry though - with more than 25 years of experience, we’ve successfully conducted loads of healthcare market research projects in big cities and have gathered all of our top tips together right here so you can ensure your next medical market research project goes off without a hitch.

Read More

Topics: healthcare market research

Five easy-to-follow rules for reaching HCPs via email

Posted by GKA on 13/11/18 15:50

There’s no doubt about it: when it comes to communicating with healthcare professionals during healthcare fieldwork recruitment, email is one of the best ways to keep in touch. It’s fast, it’s easy, and it’s a fantastic way to build a rapport with your HCP respondents throughout the recruitment process. However, there are some things you need to consider when contacting HCPs this way, from complying with the relevant rules and regulations to making sure your message stands out and doesn’t get lost among the hundreds of other emails they receive each day. In this blog, we've put together our top tips for communicating with HCPs via email during the healthcare fieldwork recruitment process to make sure your respondents remain engaged and that your project is a success.

Read More

Topics: healthcare market research

Subscribe to Email Updates

Recent Posts